European Patent Law & Practice provides guidance to in-house and outside counsel prosecuting and litigating patents in Europe. The product includes information on applications, expert examinations, licenses and all relevant patent laws affecting the... Read More
WASHINGTON, D.C. - (Mealey's) In a divided ruling, the Federal Circuit U.S. Court of Appeals on Aug. 16 reversed a New York federal judge's determination that composition claims related to isolated DNA molecules are patent-ineligible products... Read More
By Joshua Heslinga Late yesterday, a jury awarded ActiveVideo $115 million from Verizon, concluding the trial phase of the heated patent litigation. The Virginian Pilot reports on the verdict, and here is the verdict form . Our prior blog entries... Read More
WASHINGTON, D.C. - (Mealey's) Endorsing a "clear and convincing" standard for proving patent invalidity, the U.S. Supreme Court on June 9 sided with a patent holding firm in its longstanding dispute with defendant Microsoft Corp. ( Microsoft... Read More
WASHINGTON, D.C. - (Mealey's) Less than a year after it returned to the Federal Circuit U.S. Court of Appeals a patent lawsuit over diagnostic test kits for determining hereditary risk of breast and ovarian cancer, the U.S. Supreme Court on Nov. 30... Read More
WASHINGTON, D.C. - (Mealey's) The scope of statutory rights bestowed upon federal contractor universities and their researchers was debated Feb. 28 at the U.S. Supreme Court in a dispute over patented HIV detection methods ( Board of Trustees of the... Read More
On March 15, 2011, the United States Court of Appeals for the Federal Circuit, on petition for writ of mandamus, issued its decision in In re BP Lubricants USA Inc. , No. M960 (Fed. Cir. Mar. 15, 2011) [ enhanced version available to lexis.com subscribers... Read More
WASHINGTON, D.C. - (Mealey's) The U.S. Supreme Court on June 27 agreed to take up a dispute over the proper procedures for courts to use in proceedings initiated under 35 U.S. Code Section 145, which allows applicants to file a civil action in a federal... Read More
WASHINGTON, D.C. - (Mealey's) Four months after inviting the views of the U.S. solicitor general, the U.S. Supreme Court on Nov. 1 agreed to hear a case that could better define the rights of federal contractor universities in patent disputes arising... Read More
The United States Patent and Trademark Office (PTO) denied a rock band’s application for a federal trademark of the band’s name, “The Slants” under a provision of the Lanham Act prohibiting the registration of trademarks that may... Read More
WASHINGTON, D.C. - (Mealey's) The Second Circuit U.S. Court of Appeals properly found standing lacking in a trademark infringement case by virtue of a covenant not to sue, an attorney for Nike Inc. told the U.S. Supreme Court Nov. 7 ( Already LLC... Read More
By Matthew K. K. Sumida* *Information Resource Editor, UCLA Law Review, Volume 58. J.D. Candidate, UCLA School of Law, 2011; B.S., University of Southern California, 2004 Excerpt from Defendant Class Actions and Patent Infringement Litigation , 58... Read More
Claim must ‘inform with reasonable certainty’ By Tamsen Barrett On Monday, June 2, 2014, the Supreme Court articulated its standard for indefiniteness under 35 USC §112, second paragraph and held that 35 USC §112, second paragraph... Read More
WASHINGTON, D.C. - (Mealey's) The U.S. Supreme Court will review the Federal Circuit U.S. Court of Appeals' ruling, in a case of first impression, that the counterclaim provision of the Hatch-Waxman Act is available "only if the listed patent... Read More
WASHINGTON, D.C. - (Mealey's) Generic drug manufacturers may employ the Hatch-Waxman Act's counterclaim provision - known as a Section viii - to force correction of an inaccurate label when the brand-name drug's description overstates a particular... Read More